06:29:13 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-17 Bokslutskommuniké 2024
2024-11-08 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-06-07 Ordinarie utdelning POLYMER 0.00 SEK
2024-06-05 Årsstämma 2024
2024-05-08 Kvartalsrapport 2024-Q1
2024-02-16 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-08-16 Kvartalsrapport 2023-Q2
2023-06-05 Ordinarie utdelning POLYMER 0.00 SEK
2023-06-02 Årsstämma 2023
2023-05-10 Kvartalsrapport 2023-Q1
2023-02-15 Extra Bolagsstämma 2023
2023-02-10 Bokslutskommuniké 2022
2022-11-10 Kvartalsrapport 2022-Q3
2022-08-10 Kvartalsrapport 2022-Q2
2022-06-09 Ordinarie utdelning POLYMER 0.00 SEK
2022-06-08 Årsstämma 2022
2022-05-10 Kvartalsrapport 2022-Q1
2022-02-25 Bokslutskommuniké 2021
2021-12-20 Extra Bolagsstämma 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-25 Kvartalsrapport 2021-Q2
2021-06-03 Årsstämma 2021
2021-05-25 Kvartalsrapport 2021-Q1

Beskrivning

LandSverige
ListaSpotlight
SektorMaterial
IndustriPlast, kemikalier & fetter
Polymer Factory Sweden är specialiserade inom nanoteknologi. Bolaget utvecklar polymera material som används i diverse medicinska behandlingar. Lösningarna används huvudsakligen som komplement i olika behandlingar för cancer och neurologiska sjukdomar. Utöver huvudverksamheten erbjuder bolag kalibreringsteknik som används i olika analyser- och livsmedelstestning.
2023-12-13 10:03:05

Polymer Factory Sweden AB ("Polymer Factory" or the "Company") will adjust its financial targets for the fiscal year 2023. The reason for the change is an update in timelines for projects that were estimated to move forward in late 2023. These projects are instead anticipated for early 2024. The previously communicated financial target of net sales of approx. SEK 3.6 million will be adjusted to an operating income of approx. SEK 2.7 million.

Polymer Factory has during 2023 taken many steps forward towards realizing commercial projects with customers and partners, in accordance with its plan for the year; however, as emphasized in interim reports, lead times for projects in the life science sector are often long and dependent on the customers' project timelines. The reduction in turnover is not related to a single event and is not considered to deviate from the financial reporting in previously released interim reports.

The Company emphasizes that the adjusted target is indicative, as no financial statements have yet been completed.

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 13-12-2023 10:03 CET.